Composition for inhibiting growth of bacterium having menaquinone synthesis pathway through futalosine or futalosine derivative
AssigneeNoster Inc.
InventorsHidenori Matsui, Marina Kawaguchi
Life of this patent
Estimating the term…
Abstract
The present invention provides a composition for inhibiting proliferation of a bacterium provided with a menaquinone synthesis route via futalosine or a futalosine derivative, which contains a fatty acid having 18 carbon atoms and a hydroxyl group at the 10-position as an active ingredient. Furthermore, the present invention provides a composition for preventing or treating a disease caused by a bacterium provided with a menaquinone synthesis route via futalosine or a futalosine derivative.
Claims9
A method for preventing development of a disease selected from the group consisting of acute gastritis, chronic gastritis, nodular gastritis, stomach cancer, stomach MALT lymphoma, diffuse large B-cell lymphoma, idiopathic thrombocytopenia purpura, chronic urticaria, and Parkinson's disease in a patient infected with Helicobacter pylori or Helicobacter suis comprising administering a fatty acid having 18 carbon atoms and a hydroxyl group at the 10-position to a subject.
A method for preventing development of food poisoning in a subject infected with Campylobacter jejuni or Campylobacter coli comprising administering a fatty acid having 18 carbon atoms and a hydroxyl group at the 10-position to the subject.
A method for preventing Guillain-Barre syndrome in a patient infected with Campylobacter jejuni or Campylobacter coli comprising administering a fatty acid having 18 carbon atoms and a hydroxyl group at the 10-position to a subject.
Dependencies are inferred from the claim text.